Authors' response: Spironolactone but not flutamide administration prevents bone loss in hyperandrogenic women treated with gonadotropin-releasing hormone agonist
P. Moghetti et al., Authors' response: Spironolactone but not flutamide administration prevents bone loss in hyperandrogenic women treated with gonadotropin-releasing hormone agonist, J CLIN END, 84(12), 1999, pp. 4747-4747